Reappraisal of the Prostaglandin E1 Dose for Early Newborns with Patent Ductus Arteriosus-Dependent Pulmonary Circulation

The usual initial dose of prostaglandin E1 (PGE1) for ductal-dependent congenital heart disease (CHD) is 50–100 ng/kg/minute. The aim of this study was to review our experience of a low initial dose of PGE1 treatment in early newborns with congenital heart disease and patent ductus arteriosus (PDA)-...

全面介紹

書目詳細資料

發表在:	Pediatrics and Neonatology
Main Authors:	Fu-Kuei Huang, Chu-Chuan Lin, Ta-Cheng Huang, Ken-Pen Weng, Po-Yen Liu, Ying-Yao Chen, Hsiao-Ping Wang, Luo-Ping Ger, Kai-Sheng Hsieh
格式:	Article
語言:	英语
出版:	Elsevier 2013-04-01
主題:	congenital heart disease patent ductus arteriosus prostaglandin E1
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S1875957212001684